Pharma Mar S.A. Cash Flow Conversion Efficiency

Latest as of December 2025: 0.133x

Pharma Mar S.A. cash flow conversion efficiency. Based on the latest financial reports, Pharma Mar S.A. (PHM) has a cash flow conversion efficiency ratio of 0.133x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€33.58 Million ≈ $39.26 Million USD) by net assets (€251.83 Million ≈ $294.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Pharma Mar S.A. (2002–2025)

Cash flow conversion efficiency of Pharma Mar S.A. from 2002 to 2025. This chart illustrates how Pharma Mar S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View PHM stock price for real-time trading data and today's change.

Pharma Mar S.A. Cash Flow Conversion Ratio Explained

Pharma Mar S.A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Pharma Mar S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharma Mar S.A. ranked by their cash flow conversion efficiency. Also see PHM company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Cyient Limited NSE:CYIENT	0.071x
Teladoc Inc NYSE:TDOC	0.071x
Shenzhen Qingyi Photomask Ltd SHG:688138	0.031x
Nolato AB (publ) ST:NOLA-B	0.051x
Guangdong Tapai Group Co Ltd SHE:002233	0.040x
China Resources Chemical Innovative Materials Co. Ltd. SHE:301090	-0.030x
Aryzta AG SW:ARYN	0.302x
Gs Retail KO:007070	0.104x

Annual Cash Flow Conversion Efficiency for Pharma Mar S.A. (2002–2025)

The table below shows the annual cash flow conversion efficiency of Pharma Mar S.A. from 2002 to 2025. Review Pharma Mar S.A. free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€251.83 Million ≈ $294.42 Million	€53.13 Million ≈ $62.11 Million	0.211x	+629.35%
2024-12-31	€208.36 Million ≈ $243.59 Million	€6.03 Million ≈ $7.05 Million	0.029x	+141.61%
2023-12-31	€193.44 Million ≈ $226.15 Million	€-13.45 Million ≈ $-15.72 Million	-0.070x	-140.44%
2022-12-31	€222.96 Million ≈ $260.66 Million	€38.32 Million ≈ $44.80 Million	0.172x	+19.09%
2021-12-31	€177.92 Million ≈ $208.00 Million	€25.68 Million ≈ $30.02 Million	0.144x	-94.69%
2020-12-31	€102.72 Million ≈ $120.09 Million	€278.94 Million ≈ $326.11 Million	2.716x	+177.46%
2019-12-31	€7.46 Million ≈ $8.72 Million	€-26.14 Million ≈ $-30.56 Million	-3.505x	-274.86%
2018-12-31	€17.47 Million ≈ $20.43 Million	€-16.34 Million ≈ $-19.10 Million	-0.935x	-1373.18%
2017-12-31	€22.98 Million ≈ $26.87 Million	€-1.46 Million ≈ $-1.71 Million	-0.063x	+63.41%
2016-12-31	€48.49 Million ≈ $56.70 Million	€-8.41 Million ≈ $-9.84 Million	-0.174x	-214.15%
2015-12-31	€73.04 Million ≈ $85.39 Million	€11.10 Million ≈ $12.98 Million	0.152x	-58.70%
2014-12-31	€60.07 Million ≈ $70.23 Million	€22.11 Million ≈ $25.85 Million	0.368x	+11.32%
2013-12-31	€49.44 Million ≈ $57.79 Million	€16.34 Million ≈ $19.11 Million	0.331x	+102.63%
2012-12-31	€38.73 Million ≈ $45.27 Million	€6.32 Million ≈ $7.39 Million	0.163x	+231.48%
2011-12-31	€34.50 Million ≈ $40.34 Million	€-4.28 Million ≈ $-5.01 Million	-0.124x	+80.24%
2010-12-31	€34.86 Million ≈ $40.76 Million	€-21.90 Million ≈ $-25.60 Million	-0.628x	-14.01%
2009-12-31	€41.14 Million ≈ $48.09 Million	€-22.67 Million ≈ $-26.50 Million	-0.551x	+23.75%
2008-12-31	€49.34 Million ≈ $57.69 Million	€-35.66 Million ≈ $-41.69 Million	-0.723x	-45.25%
2007-12-31	€98.81 Million ≈ $115.52 Million	€-49.16 Million ≈ $-57.47 Million	-0.497x	+4.99%
2006-12-31	€107.17 Million ≈ $125.30 Million	€-56.11 Million ≈ $-65.60 Million	-0.524x	-470.66%
2005-12-31	€360.04 Million ≈ $420.93 Million	€-33.03 Million ≈ $-38.62 Million	-0.092x	+80.98%
2003-12-31	€139.28 Million ≈ $162.83 Million	€-67.18 Million ≈ $-78.54 Million	-0.482x	-125.85%
2002-12-31	€166.90 Million ≈ $195.12 Million	€-35.64 Million ≈ $-41.67 Million	-0.214x	--

About Pharma Mar S.A.

MC:PHM Spain Biotechnology

Market Cap

$1.32 Billion

€1.13 Billion EUR

Market Cap Rank

#7473 Global

#64 in Spain

Share Price

€65.40

Change (1 day)

-0.76%

52-Week Range

€64.25 - €103.60

All Time High

€129.23